Characterization of the Genomic and Immunological Diversity of Malignant Brain Tumors Through Multi-Sector Analysis.
Sign Up to like & getrecommendations! Published in 2021 at "Cancer discovery"
DOI: 10.1158/2159-8290.cd-21-0291
Abstract: Despite some success in secondary brain metastases, targeted or immune-based therapies have shown limited efficacy against primary brain malignancies such as glioblastoma (GBM). While the intratumoral heterogeneity of GBM is implicated in treatment resistance, it… read more here.
Keywords: brain tumors; malignant brain; genomic immunological; characterization genomic ... See more keywords